Evidence map›Paper›PMID 40567997›Full record

ArticleOpen forum infectious diseases2025

Mental Health, Substance Use, and Tuberculosis Preventive Therapy in People With HIV: A Prospective Cohort Study.

Ann E Johnson, Lucy Chimoyi, Sheela Shenoi, Marie A Brault, Laura Forastiere, Salome Charalambous, Violet Chihota, J Lucian Davis

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ann E JohnsonYale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-7444-3857
Lucy ChimoyiImplementation Research Division, The Aurum Institute, Parktown, Johannesburg, South Africa.ORCID https://orcid.org/0000-0002-0083-8319
Sheela ShenoiEpidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-7654-4344
Marie A BraultDepartment of Population Health, New York University Grossman School of Medicine, New York, New York, USA.ORCID https://orcid.org/0000-0002-7152-785X
Laura ForastiereDepartment of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
Salome CharalambousImplementation Research Division, The Aurum Institute, Parktown, Johannesburg, South Africa.ORCID https://orcid.org/0000-0001-7143-1009
Violet ChihotaImplementation Research Division, The Aurum Institute, Parktown, Johannesburg, South Africa.
J Lucian DavisEpidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-8629-9992

Funding

Medical Scientist Training ProgramT32GM136651 · NIGMS · YALE UNIVERSITY · PI BARBARA I KAZMIERCZAK · 2020 to 2026
$16.5M
Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
NRSA Training CoreTL1TR001864 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$9.9M
Engaging providers, community members, and young women to adapt and pilot a youth-friendly sexual and reproductive health package in low-income communities in IndiaK01TW011480 · FIC · YALE UNIVERSITY · PI BRAULT, MARIE AMANDA · 2020 to 2023
$591k
FIC NIH HHS D43 TW010540FIC NIH HHS K01 TW011480NCATS NIH HHS TL1 TR001864NIGMS NIH HHS T32 GM136651
6 · The paper itself

Abstract

Background: Because of the association of mental health and substance use disorders with higher HIV mortality and decreased retention in care, we investigated their frequency and impact on tuberculosis preventive therapy (TPT) adherence and completion among people with HIV (PWHIV) initiating TPT. Methods: We conducted a prospective, longitudinal cohort study with a nested mixed methods study in 2 Johannesburg, South Africa, facilities. Participants were PWHIV on antiretroviral therapy initiating TPT between August and December 2023. We measured TPT adherence and completion with electronic medication boxes. We used validated tools to measure symptoms of anxiety, depression, alcohol use, and other substance use at enrollment and 12 weeks. We constructed multivariable regression models to determine associations of these variables with TPT adherence and completion, adjusting for age, sex, and time on antiretroviral therapy. We interviewed participants about mental health and experiences with TPT and analyzed responses using deductive content analysis. Results: Among 224 PWHIV, 111 (50%) completed TPT. Eighty-one (36%) screened positive for depression symptoms and 63 (28%) for anxiety symptoms. Seventy-six (34%) reported unhealthy alcohol use and 60 (27%) tobacco use. Using multivariable models adjusting for confounders, only depression symptoms were significantly and negatively associated with adherence (9% fewer doses; 95% confidence interval, .4-16; Conclusions: Symptoms of depression, anxiety, unhealthy alcohol use, and tobacco use were common among PWHIV initiating TPT. Depression symptoms were strongly and independently associated with TPT nonadherence and noncompletion.

Indexed as

depressionHIVmedication adherenceSouth Africatuberculosis

Identifiers

PMID40567997
PMCPMC12188208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.